| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Transmission of drug-resistant HIV-1 is stabilizing in Europe.
|
J Infect Dis
|
2009
|
2.60
|
|
2
|
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
|
PLoS One
|
2011
|
2.36
|
|
3
|
Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.
|
PLoS One
|
2010
|
2.04
|
|
4
|
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.
|
Proc Natl Acad Sci U S A
|
2011
|
1.93
|
|
5
|
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.
|
Retrovirology
|
2009
|
1.58
|
|
6
|
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.
|
J Gen Virol
|
2007
|
1.41
|
|
7
|
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
|
J Infect Dis
|
2010
|
1.40
|
|
8
|
Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
|
J Gen Virol
|
2009
|
1.40
|
|
9
|
Pyrosequencing for detection of lamivudine-resistant hepatitis B virus.
|
J Clin Microbiol
|
2004
|
1.39
|
|
10
|
Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains.
|
J Clin Microbiol
|
2002
|
1.30
|
|
11
|
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.
|
Retrovirology
|
2013
|
1.30
|
|
12
|
Performance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation.
|
PLoS One
|
2011
|
1.29
|
|
13
|
Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.
|
PLoS One
|
2012
|
1.24
|
|
14
|
PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data.
|
PLoS One
|
2013
|
1.23
|
|
15
|
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
|
J Virol
|
2004
|
1.17
|
|
16
|
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
|
J Gen Virol
|
2005
|
1.16
|
|
17
|
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men.
|
Antivir Ther
|
2006
|
1.14
|
|
18
|
Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization.
|
J Clin Microbiol
|
2003
|
1.12
|
|
19
|
Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy.
|
J Virol
|
2006
|
1.10
|
|
20
|
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients.
|
J Virol Methods
|
2003
|
1.09
|
|
21
|
Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland.
|
J Virol
|
2010
|
1.08
|
|
22
|
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
|
J Gen Virol
|
2005
|
1.06
|
|
23
|
Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.
|
PLoS One
|
2013
|
1.04
|
|
24
|
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
|
Virology
|
2008
|
1.04
|
|
25
|
Treatment of HIV infection: Swedish recommendations 2009.
|
Scand J Infect Dis
|
2009
|
1.03
|
|
26
|
Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon.
|
AIDS Res Hum Retroviruses
|
2002
|
1.01
|
|
27
|
Limited cross-border infections in patients newly diagnosed with HIV in Europe.
|
Retrovirology
|
2013
|
1.01
|
|
28
|
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
|
AIDS
|
2003
|
1.00
|
|
29
|
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
|
J Virol
|
2005
|
0.99
|
|
30
|
A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.
|
J Virol Methods
|
2003
|
0.98
|
|
31
|
Characterization of novel recombinant HIV-1 genomes using the branching index.
|
Virology
|
2003
|
0.97
|
|
32
|
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.
|
BMC Infect Dis
|
2014
|
0.96
|
|
33
|
Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras.
|
J Clin Virol
|
2010
|
0.96
|
|
34
|
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
|
AIDS Res Hum Retroviruses
|
2003
|
0.95
|
|
35
|
Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child.
|
J Infect Dis
|
2002
|
0.95
|
|
36
|
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.
|
J Clin Microbiol
|
2008
|
0.94
|
|
37
|
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.
|
J Virol
|
2010
|
0.93
|
|
38
|
Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014.
|
Infect Dis (Lond)
|
2015
|
0.92
|
|
39
|
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.
|
Retrovirology
|
2012
|
0.91
|
|
40
|
Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.
|
J Infect Dis
|
2013
|
0.91
|
|
41
|
Phylogenetic analysis of the Latvian HIV-1 epidemic.
|
AIDS Res Hum Retroviruses
|
2012
|
0.90
|
|
42
|
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
|
J Clin Microbiol
|
2007
|
0.89
|
|
43
|
Multiple HIV-1 introductions into the Swedish intravenous drug user population.
|
Infect Genet Evol
|
2008
|
0.89
|
|
44
|
Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis?
|
J Infect Dis
|
2011
|
0.88
|
|
45
|
Antiretroviral treatment of HIV infection: Swedish recommendations 2007.
|
Scand J Infect Dis
|
2007
|
0.88
|
|
46
|
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
|
PLoS One
|
2013
|
0.88
|
|
47
|
CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.
|
AIDS Res Hum Retroviruses
|
2002
|
0.87
|
|
48
|
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
|
Retrovirology
|
2008
|
0.86
|
|
49
|
Can the further clinical development of bevirimat be justified?
|
AIDS
|
2010
|
0.85
|
|
50
|
Science in court: the myth of HIV fingerprinting.
|
Lancet Infect Dis
|
2011
|
0.85
|
|
51
|
Antiretroviral treatment of HIV infection: Swedish recommendations 2005.
|
Scand J Infect Dis
|
2006
|
0.85
|
|
52
|
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
|
J Med Virol
|
2010
|
0.84
|
|
53
|
Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms.
|
J Acquir Immune Defic Syndr
|
2011
|
0.83
|
|
54
|
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.
|
PLoS One
|
2011
|
0.83
|
|
55
|
HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.
|
Ann N Y Acad Sci
|
2011
|
0.82
|
|
56
|
A single early introduction of HIV-1 subtype B into Central America accounts for most current cases.
|
J Virol
|
2013
|
0.82
|
|
57
|
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections.
|
Cytokine
|
2009
|
0.82
|
|
58
|
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
|
J Med Virol
|
2012
|
0.81
|
|
59
|
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.
|
Infect Genet Evol
|
2013
|
0.81
|
|
60
|
Performance of the Simplexa™ Flu A/B & RSV Direct Kit on respiratory samples collected in saline solution.
|
Scand J Infect Dis
|
2014
|
0.81
|
|
61
|
Therapy failure resulting from superinfection by a drug-resistant HIV variant.
|
Antivir Ther
|
2012
|
0.81
|
|
62
|
Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country.
|
Int J Mol Epidemiol Genet
|
2012
|
0.80
|
|
63
|
Short communication: HIV type 2 dynamics.
|
AIDS Res Hum Retroviruses
|
2005
|
0.80
|
|
64
|
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.
|
Antivir Ther
|
2013
|
0.79
|
|
65
|
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
|
PLoS Med
|
2015
|
0.78
|
|
66
|
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007.
|
Scand J Infect Dis
|
2008
|
0.78
|
|
67
|
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.
|
Scand J Infect Dis
|
2011
|
0.78
|
|
68
|
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.
|
Scand J Infect Dis
|
2014
|
0.77
|
|
69
|
Delayed HIV diagnosis common in Sweden, 2003-2010.
|
Scand J Infect Dis
|
2014
|
0.77
|
|
70
|
Daily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutrality.
|
PLoS One
|
2011
|
0.77
|
|
71
|
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.
|
AIDS Res Hum Retroviruses
|
2011
|
0.77
|
|
72
|
Defining HIV-1 transmission clusters based on sequence data: a systematic review and perspectives.
|
AIDS
|
2017
|
0.76
|
|
73
|
Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch.
|
AIDS Res Hum Retroviruses
|
2013
|
0.76
|
|
74
|
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model.
|
Epidemiology
|
2016
|
0.75
|
|
75
|
Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates.
|
AIDS Res Hum Retroviruses
|
2006
|
0.75
|
|
76
|
Modulation frequency response of a bistable system with noise.
|
Phys Rev E Stat Nonlin Soft Matter Phys
|
2004
|
0.75
|
|
77
|
[Darwin's principles direct the development of A/H1N1. Influenza virus evolution enormously complex--the new influenza is not and exception].
|
Lakartidningen
|
2009
|
0.75
|
|
78
|
Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection.
|
AIDS Res Hum Retroviruses
|
2004
|
0.75
|
|
79
|
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.
|
PLoS Biol
|
2017
|
0.75
|
|
80
|
Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets.
|
AIDS Res Hum Retroviruses
|
2005
|
0.75
|